To clarify partly inconsistent results in gene expression of cytochromes P450 (CYP) in the circulation, we undertook a systematic study over a long time period in 19 healthy men and women. CYP specific mRNA for 1A2, 1B1, 2E1 and 3A4 was studied in the leukocytes collected repeatedly on 20 occasions over a 10-week period. Our study revealed a varying pattern of CYP expression over time. CYP3A4 specific mRNA exhibited the largest intra-individual variation with an average coefficient of variation between 40 and 250%. CYP1B1 and CYP2E1 did not vary as much (39-110%). CYP1A2 was sporadically detected in only ten individuals, but varied considerably when measurable (61-256%). The expression in CYP1B1 was significantly higher in women than in men (P = 0.02). We conclude that CYP gene expression in blood varies considerably over time. It is conceivable that the variation reflects a hitherto unknown influence of exogenous or endogenous factors such as hormones, cytokines, and other circulating factors on the hematogeneous cytochromes.
INTRODUCTION
The cytochrome P450 (CYP) enzymes belong to a multigene family of detoxifying enzymes. They are involved in the metabolism of exogenous as well as endogenous substances. 1 The main location of these enzymes is the liver. However, expression of CYP enzymes has been described in a wide variety of tissues, including intestine, lungs, blood etc. [2] [3] [4] Genetic polymorphisms and/or chemical environmental influence contribute to the large variation in the activity of the CYP enzymes, which explains interindividual differences in the ability to metabolise drugs. Knowledge about how hormonal or dietary factors affect the expression of CYP enzymes is important for the individualisation of drug doses in clinical practice. Some of the genetic polymorphisms have been extensively investigated. 5 This is also true for the influence by non-genetic factors such as drugs, environmental chemicals, disease, or endogenous hormones. 5, 6 Studies of variation in drug metabolism are typically performed using conventional pharmacokinetics approaches in vivo or metabolic assays in vitro. Today gene expression of drug metabolising enzymes is easily measurable with sensitive methods in various tissues. [7] [8] [9] CYP enzyme activity in the blood was first described about 30 years ago. 10 Although the leukocytes are present in enormous numbers with a rapid turnover, 11 drug metabolism in blood is probably of negligible quantitative and clinical importance. However, we cannot rule out an importance of the hematogeneous CYP enzymes in chemically induced toxicity of the bone marrow. Severe blood dyscrasias induced by drugs are rarely but regularly reported. The cytochrome P450 enzymes in the blood may be of etiologic importance in these kind of adverse drug reactions. Therefore studies in blood may give important information about the mechanisms involved in such reactions.
Given this situation we have studied the pattern of gene expression of different CYP enzymes. Previous data of our group have been partly inconsistent. Therefore, we studied the consistency of CYP gene expression in blood leukocytes over a long time period. We here report a large variation in expression of four different CYP enzyme genes in 19 healthy individuals over a period of 10 weeks.
RESULTS
The CYP gene expression in blood varied considerably over time ( Figure 1 ). The variation was quantified as the coefficient of variation (CV) calculated on the basis of the mean concentration of mRNA at the 20 time points and the standard deviation (SD) over the same time. When based on the amount of total RNA added to each reaction the CV for CYP1A2 and CYP3A4 varied considerably between individuals, from 61% to 256% (Figure 2a and Table 1 ). CYP1B1 and CYP2E1 varied less with a CV of 39-110% (Figure 2a) .
The methodological variation of the real-time PCR was comparatively low, with CV values between 20 and 25% as tested for each of the enzymes in duplicates on three different occasions (data not shown).
As expected the variation in expression of the house-keeping genes TBP and 18S rRNA varied less over time, with an average CV of 67 and 98%, respectively. There was a signifi- The Pharmacogenomics Journal cant correlation between TBP and 18S rRNA concentration within each individual (r = 0.7-0.9). For this reason the CYP gene expression was also based on the concentration of TBP which was successfully used in an earlier study. 9 The CV was higher when based on TBP compared to when based on the amount total RNA. For CYP1A2 it reached values between 133 and 237% whereas for CYP1B1 and CYP2E1 it was within the range of 42-183%. CYP3A4 varied considerably, with CV values of 69-365% (Table 1) .
To determine the intra-day variation in CYP gene expression blood was collected from two healthy individuals at four different times within the same day. The intra-day CV for CYP1A2 was 140% whereas for CYP1B1, CYP2E1 and CYP3A4 the corresponding figures were 27, 59 and 42%, respectively (data not shown).
CYP1A2 gene expression was detectable only sporadically in 10 individuals (five males and five females). In none of the other nine individuals was CYP1A2 mRNA measurable at any time (Table 1 ). CYP2E1 and CYP3A4 were also detected sporadically in some volunteers as shown in Table 1 . In contrast, CYP1B1 was consistently expressed in all volunteers at all time-points.
We also looked at the gender differences. Although the variation in CV was greater in females for CYP3A4 this sex difference did not reach statistical significance ( Figure 2 ). However, the CYP1B1 gene expression over the sampling interval, calculated as the AUC, was significantly higher in females (median: 19.4; range: 10.5-23.9) than males (median: 13.4; range: 6.9-22.9) when based on total RNA (P = 0.02) but not when based on TBP (P = 0.09). None of the other enzymes showed any significant sex difference. The gene expression at the time of menstruation and ovulation showed no significant differences for CYP1B1, CYP2E1 or CYP3A4 ( Figure 3) . CYP1A2 was not possible to study in this respect as many of the measurements were below the detection limit.
DISCUSSION
Gene expression of cytochromes P450 in blood has been very little studied. We have previously described cytochrome P450 gene expression in blood using a sensitive realtime RT-PCR method. 9 However, the gene expression was not consistent when studied repeatedly in one individual on different occasions. 12 Therefore, we hypothesised that cytowww.nature.com/tpj chrome P450 gene expression in blood is rapidly changing over time due to endogenous and/or exogenous factors. We here describe a considerable variation over time of the cytochrome P450 specific mRNAs in blood, with a CV between 40 and 365%. This variation is in all probability a result of endogenous or exogenous stimuli and the contribution of methodological variation in the assay is only 20-25%.
Among the investigated CYP species, consistent gene expression was found only for CYP1B1 in all subjects at all time points. None of the other CYP enzyme genes were consistently expressed. We set the detection limit at 38 cycles in our method, which corresponds to 1000 molecules or 10 Ϫ21 moles of CYP specific mRNA per ng total RNA. Using these criteria CYP1A2 mRNA was detected only sporadically. Only ten of the 19 individuals had detectable, but low, levels of CYP1A2 mRNA at 2-13 of the 20 time points. CYP3A4, and to a lesser extent CYP2E1, also showed a sporadic expression pattern over time. The levels of the house-keeping genes in these samples were 'normal'.
There are important differences in function, activities and turnover rate of different subsets of leukocytes. 11 The relatively low intra-day variation in our study of CYP1B1, CYP2E1 and CYP3A4 shown in two individuals indicated that the large variation seen over a longer time probably reflects events taking place during the cell maturation in the marrow and migration to the peripheral circulation.
Large hormonal variations occur during the menstrual cycle. One could speculate that steroid hormones are involved in the variation of cytochrome P450 in the blood. It has earlier been shown that eg cytochrome P450-dependent metabolism of caffeine, theophylline and phenytoin is faster during the middle and late phases of the menstrual cycle than in the early phase. [13] [14] [15] However, other studies indicate that there is no difference in in vivo metabolism of drugs in different phases of the menstrual cycle. [16] [17] [18] [19] Our results are in agreement with these investigators, as we were not able to detect any significant differences in gene expression for any of the studied enzymes at menstruation vs ovulation. This indicates that exogenous factors are relatively important for the regulation of CYP gene expression in blood.
Ethylmorphine N-demethylation (CYP3A specific metabolism) was earlier found not to be related to steroidal hormone levels. 20 These investigators showed a larger variation in the metabolism in females compared to males but could not explain the variation on the basis of hormonal levels. In concordance with this we also observed a large variation in the CYP3A4 gene expression (based on TBP) over time. This variation was larger for women than men, although not significantly. CYP1B1 has earlier been described as the major cytochrome P450 in blood. 9, 21, 22 We also found this to be the case in our material of leukocytes from 19 healthy individuals. It is by far the most frequently expressed of the four CYP transcripts and consistently measurable in all individuals on all study occasions. Its role in the metabolism of endogenous substances might explain why it is expressed at high levels. The low CV of the gene expression for CYP1B1 might also reflect its importance in endogenous functions. The higher expression of CYP1B1 in females than in males is yet another sign that CYP1B1 is active in the hormonal homeostasis consistent with its role in the metabolism of estrogens. 23 To our knowledge this is the first time that CYP1B1 is described as differently expressed between the sexes with higher AUC values in women than in men. The sex difference indicates that endogenous steroid hormones or related substances play a role in the regulation of this enzyme. The CYP1A2 enzyme, with a similar regulation as CYP1B1, although exerted through the Ah-receptor, has earlier been shown to exhibit sex differences. 24, 25 Women have a lower CYP1A2 enzyme activity than men. 24, 25 This discrepancy is difficult to explain. Unfortunately, we were not able to study blood CYP1A2 in this respect as the levels of the corresponding gene transcript were often below the detection limit.
CYP1A2 has not previously been described in blood, in contrast to CYP1A1. 26 The consistently low levels of CYP1A2 detected by us support the fact that CYP1A2 is of little importance in blood, if at all expressed as protein.
Surprisingly, CYP3A4 mRNA was found in several blood samples; the identity was verified by sequencing. This is in contrast to the results of other investigators. 27 Janardan et al 27 were able to detect CYP3A5 but not CYP3A4. The sporadic expression in many of the volunteers in this work may explain why CYP3A4 gene transcript has been found in blood only by some investigators.
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Raucy et al have demonstrated CYP2E1 to be expressed in blood 28 and to be induced by alcohol intake. 29 In our study we were able to detect CYP2E1 mRNA in almost all samples. Although assessment of alcohol intake during the last few days was made by the volunteer at blood withdrawal, our study was not designed to study the induction of the enzyme by alcohol.
We have earlier shown that blood leukocyte CYP mRNA expression does not reflect the liver CYP mRNA expression. 9 Our findings in this paper contribute to understanding of this difference. Even though a similar scenario with variation in gene expression over time may take place in the liver, the variation in blood is probably a lot faster as this organ has a much higher cell turnover than liver.
In conclusion, we have shown that four CYP gene transcripts are present in blood but vary considerably over time. The reason for the variation is unclear. However, the mechanism of influence on blood CYP gene expression and the sex difference in CYP1B1 mRNA levels are findings worthy of further studies. Future studies of hematogeneous CYP species should take the spontaneous variation in levels into consideration.
MATERIALS AND METHODS

Reagents
All chemicals were purchased from Sigma (St Louis, MO, USA) or BDH (Poole, UK) and were of at least analytical grade. Reagents for real-time PCR were purchased from Applied Biosystems. 
Volunteers
Seven ml of blood was collected in EDTA tubes on 20 occasions during a 10-week period from nine male volunteers (mean age: 30; range: 24-38) and 10 female volunteers (mean age: 35; range: 29-42). All subjects were Caucasians and considered healthy on the basis of medical history, physical examination and laboratory tests of renal, hepatic and haematological function. The women were not pregwww.nature.com/tpj nant or using any kind of hormonal contraceptives and were monitoring their menstrual cycle during the study. All had regular menstrual cycles of 23-32 days. At each blood collection, the volunteers were asked to fill in a questionnaire about their diet, alcohol intake, smoking habits, medical drugs used, and possible illness since the previous sampling time. All 19 volunteers participated throughout the study with only four missing data of a total of 380.
In a separate experiment 7 ml of blood was collected on four occasions in the same day (at 10, 12, 14 and 16 o'clock) from two individuals in order to study the intra-day variation. The volunteers were included after informed consent and the study was approved by the Ethics Committee at the Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden.
RNA and cDNA Preparation
Total RNA was prepared from 3 ml whole blood using the RNeasy Blood mini kit (Qiagen, Hilden Germany) as described by the manufacturer. The RNA concentrations were measured spectrophotometrically at 260 nm on a Du  530 spectrophotometer (Beckman Instruments Corp, CA, USA) with a correction for absorbance at 320 nm. Five hundred ng of total RNA was reverse transcribed into cDNA using the First strand cDNA synthesis kit (Amersham Pharmacia Biotech) as described before. 9 The final cDNA reaction mix was diluted ten times before PCR reaction.
Real-time RT-PCR
Real-time RT-PCR was performed on an ABI 7700 sequence detection system as previously described. 9 Briefly, five l of the diluted cDNA mix, corresponding to 16.7 ng total RNA, was used in a PCR reaction containing 300 nM each of forward and reverse primers, and 50 nM of the probe. The PCR was performed with an initial enzyme activation step at 94°C for 12 min followed by 50 cycles (95°C for 15 s; 60°C for 30 s). All PCR reactions were run in duplicate and at least two non-template controls were included with all PCR runs. The cycle to threshold (Ct) value was determined at the normalised fluorescent value (⌬Rn) of 0.05, where the different PCR reactions were in the logarithmic phase of amplification.
The probes, as described earlier by Finnström et al 9 were labelled with the reporter dye 6-carboxy-4,7,2Ј,7Ј-tetrachloro-fluoroscein (TET) at the 5Ј-end and a dark quencher (Dabcyl) at the 3Ј-end (SGS, Sweden or Cybergene AB, Sweden). TATA box binding protein (TBP) mRNA and 18S rRNA were used as internal control genes. The probes for both TBP and 18S mRNA were labelled with the fluorescent VIC  and used as described by the manufacturer (Applied Biosystems).
Evaluation and Statistical Analysis
The amount of cytochrome P450 specific mRNA was determined using standards of known amounts, as described earlier. 9 The amount was related to the amount of total RNA in each PCR reaction and the amount of the housekeeping TBP gene as there was a correlation between TBP and 18S rRNA gene expression. Coefficient of variation (CV) in gene expression was calculated as the standard deviation for the 20 occasions of blood collection divided by the average expression level either based on the concentration of total RNA in the PCR reactions or amount of TBP. The level of expression during the interval of sampling was calculated as 'area-under-the curve' (AUC) on the 20 time-points. Microsoft  Excel 97 and statistical program on the net (www.fon.hum.uva.nl/Service/Statistics.html) were used to analyse the data. The Wilcoxon rank sum test was used to study the inter-individual statistics. For intra-individual statistics the Wilcoxon sign rank test was used.
